This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Katrin Grobke: Innovator in Medicinal Chemistry
Introduction
Katrin Grobke is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications. Her work focuses on creating innovative solutions for serious health conditions.
Latest Patents
Katrin Grobke holds a patent for N-(4-carb-amimidophenyl)glycineamide derivatives. This patent includes compounds that can be used as inhibitors of the formation of coagulation factors Xa, IXa, and thrombin, which are induced by factor VIIa and tissue factor. These compounds have potential applications as medicaments for the treatment and prevention of thromboses, apoplexy, cardiac infarction, inflammation, and arteriosclerosis. Additionally, they may serve as antitumor agents.
Career Highlights
Katrin Grobke is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her work at this organization has allowed her to contribute to groundbreaking research and development in the field of medicine. She has a strong focus on creating effective treatments that can improve patient outcomes.
Collaborations
Katrin has collaborated with notable colleagues such as Jean Ackermann and Yu-Hua Ji. These partnerships have enhanced her research efforts and contributed to the advancement of innovative medicinal compounds.
Conclusion
Katrin Grobke's work exemplifies the impact of innovation in medicinal chemistry. Her patent and collaborations highlight her commitment to developing effective treatments for critical health issues. Her contributions continue to shape the future of medicine.